Jana Smardova

Brno, JM, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.

Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.

Journal: Cell death and differentiation

Published: March 24, 2020

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.

Journal: Leukemia & lymphoma

Published: January 11, 2019

Detection and Functional Analysis of TP53 Mutations in CLL.

Detection and Functional Analysis of TP53 Mutations in CLL.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 24, 2018

Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas.

Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas.

Journal: Oncology reports

Published: May 06, 2017

Two Approaches to Cancer Development

Two Approaches to Cancer Development

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 19, 2016

Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients.

Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients.

Journal: British journal of haematology

Published: July 30, 2016

Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas.

Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas.

Journal: Oncology reports

Published: November 11, 2015

Complex analysis of the p53 tumor suppressor in lung carcinoma.

Complex analysis of the p53 tumor suppressor in lung carcinoma.

Journal: Oncology reports

Published: October 07, 2015

Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study.

Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study.

Journal: American journal of hematology

Published: January 28, 2015

Brazilian story of the R337H p53 mutation

Brazilian story of the R337H p53 mutation

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 14, 2014

TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods.

TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: August 13, 2014

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors.

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors.

Journal: British journal of haematology

Published: April 15, 2014

Showing 1-12 of 20

Last Updated: 09/26/2026